Fingerprint
Dive into the research topics of 'A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically